The United Laboratories International Holdings Limited (HKG:3933)
Hong Kong · Delayed Price · Currency is HKD 8.47
+0.27 (3.29%)
Sep 2, 2026, 9:40 AM HKT
HKG:3933 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,858 | 13,211 | 13,759 | 13,740 | 11,334 | 9,703 |
Revenue Growth | -10.24% | -3.98% | 0.14% | 21.22% | 16.81% | 10.61% |
Gross Profit Gross Profit Growth | 3,710 | 5,514 | 6,082 | 6,335 | 4,969 | 4,211 |
Operating Income Operating Income Growth | 520.02 | 2,222 | 2,819 | 3,167 | 2,015 | 1,382 |
Net Income Net Income Growth | 539.23 | 2,086 | 2,660 | 2,701 | 1,581 | 988.1 |
Earnings Per Share EPS Growth | 0.27 | 1.11 | 1.46 | 1.49 | 0.87 | 0.54 |
EPS Growth | -75.18% | -24.41% | -1.53% | 71.11% | 61.80% | 34.90% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Intermediate Products Intermediate Products Growth | 4,018 | 5,857 | 5,753 | 4,318 | 3,385 |
Bulk Medicine Bulk Medicine Growth | 5,893 | 7,352 | 7,392 | 6,045 | 4,554 |
Finished Products Finished Products Growth | 6,698 | 4,728 | 5,024 | 4,560 | 4,035 |
Elimination Elimination Growth | -3,398 | -4,178 | -4,429 | -3,589 | -2,270 |
Total Total Growth | 13,211 | 13,759 | 13,740 | 11,334 | 9,703 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 11,069 | 10,606 | 6,330 | 4,262 | 4,743 | 3,331 |
Total Debt Total Debt Growth | 5,948 | 4,992 | 3,156 | 1,504 | 2,463 | 1,848 |
Net Cash (Debt) Net Cash Growth | 5,121 | 5,615 | 3,174 | 2,758 | 2,280 | 1,483 |
Net Cash Growth | -8.79% | 76.89% | 15.07% | 20.96% | 53.75% | 89.92% |
Net Cash Per Share Net Cash Per Share Growth | 2.61 | 2.98 | 1.75 | 1.52 | 1.25 | 0.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 3,750 | 3,199 | 2,439 | 2,031 | 1,543 |
Capital Expenditures CapEx Growth | - | -2,802 | -1,715 | -1,274 | -779.55 | -482.17 |
Free Cash Flow Free Cash Flow Growth | - | 947.32 | 1,484 | 1,165 | 1,251 | 1,060 |
Free Cash Flow Growth | - | -36.17% | 27.40% | -6.88% | 17.98% | 2.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.28% | 41.74% | 44.21% | 46.11% | 43.84% | 43.40% |
Operating Margin | 4.38% | 16.82% | 20.49% | 23.05% | 17.78% | 14.24% |
Pretax Margin | 4.84% | 19.14% | 23.90% | 24.34% | 17.71% | 12.39% |
Profit Margin | 4.55% | 15.79% | 19.33% | 19.66% | 13.95% | 10.18% |
FCF Margin | - | 7.17% | 10.79% | 8.48% | 11.04% | 10.93% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.489 | 0.420 | 0.440 | 0.400 | 0.190 | 0.120 |
Dividend Per Share Growth | -51.22% | -4.54% | 10.00% | 110.53% | 58.33% | 50.00% |
Dividend Yield | 5.61% | 4.16% | 4.07% | 7.29% | 5.35% | 4.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.84 | 9.85 | 7.94 | 4.28 | 4.98 | 6.58 |
Forward PE | 10.27 | 7.25 | 6.83 | 5.63 | 6.08 | 5.41 |
P/FCF Ratio | - | 21.69 | 14.22 | 9.93 | 6.30 | 6.13 |
PS Ratio | 1.18 | 1.56 | 1.53 | 0.84 | 0.70 | 0.67 |